(IR,2R)-2-(4'-(3-phenyl-ureido)-biphenyl-4-carbonyl)cyclopentanecarboxylic acid,
A-922500,
959122-11-3,
A 922500,
A922500,
A-922500,
UNII-44698M475X,
DGAT-1 Inhibitor 4a,
44698M475X,
(1R,2R)-2-[[4'-[[(PHENYLAMINO)CARBONYL]AMINO][1,1'-BIPHENYL]-4-YL]CARBONYL]CYCLOPENTANECARBOXYLIC ACID,
BOZRFEQDOFSZBV-DHIUTWEWSA-N,
PubChem16681,
Urea-based Analogue, 4a,
MLS006011108,
CHEMBL430405,
SCHEMBL2742723,
BDBM20716,
CTK3I5664,
DTXSID80242027,
ABP000315,
s2674,
ZINC14974393,
AKOS022179837,
BCP9000206,
CS-0308,
SB19584,
AJ-65527,
Cyclopentanecarboxylic acid, 2-((4'-(((phenylamino)carbonyl)amino)(1,1'-biphenyl)-4-yl)carbonyl)-, (1R,2R)-,
Diacyl glycerolacyltransferase 1 inhibitor,
HY-10038,
SMR004702890,
AB0008197,
RT-011136,
FT-0770793,
Y0266,
W-5538,
122A113,
J-500277,
A 922500/,
A922500;959122-11-3,
(1R)-2alpha-[4'-(3-Phenylureido)-4-biphenylylcarbonyl]cyclopentane-1beta-carboxylic acid,
(1R,2R)-2-(4'-(3-phenylureido)-[1,1'-biphenyl]-4-carbonyl)cyclopentane-1-carboxylic acid,
(1R,2R)-2-(4-{4-[(phenylcarbamoyl)amino]phenyl}benzoyl)cyclopentane-1-carboxylic acid,
(1R,2R)-2-[4-[4-(phenylcarbamoylamino)phenyl]benzoyl]cyclopentane-1-carboxylic acid,
(1R,2R)-2-({4'-[(anilinocarbonyl)amino]-1,1'-biphenyl-4-yl}carbonyl)cyclopentanecarboxylic acid,
(1R,2R)-2-[(4-{4-[(phenylcarbamoyl)amino]phenyl}phenyl)carbonyl]cyclopentane-1-carboxylic acid,
(1R,2R)-2-[[4'-[[Phenylamino)carbonyl]amino] [1,1'-biphenyl]-4-yl]carbonyl]cyclopentanecarboxylic acid,
DGAT-1 inhibitor,
Voreloxin (SNS-595),
D02RUZ,
cc-142,
C26H24N2O4,
CB11512,
DGAT-1 inhibitors (dyslipidemia/obesity),
A4382,
DGAT-1 inhibitors (dyslipidemia/obesity), Abbott,
(1R,2R)-2-(4'-(3-phenylureido)biphenylcarbonyl)cyclopentanecarboxylic acid,
Diacylglycerol acyltransferase (dyslipidemia/obesity) inhibitors, Abbott,
175414-77-4,